Abstract
The administration of drugs is a key strategy in pharmacotherapy to treat diseases. Drugs are typically developed to modulate the function of specific proteins, which are directly associated with particular disease states. Nonetheless, recent studies suggest that protein-drug interactions are rather promiscuous and the majority of pharmaceuticals exhibit activity against multiple, often unrelated proteins. Certainly, the lack of selectivity often leads to drug side effects; on the other hand, these polypharmacological attributes can be used to develop drugs acting on multiple targets within a unique disease pathway, as well as to identify new targets for existing drugs, which is known as drug repositioning. To support drug development and repurposing, we developed eMatchSite, a new approach to detect those binding sites having the capability to bind similar compounds. eMatchSite is available as a standalone software and a webserver at http://www.brylinski.org/ematchsite.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL (2006) Global mapping of pharmacological space. Nat Biotechnol 24:805–815
Wang Y, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, Suzek TO, Wang J, Xiao J, Zhang J, Bryant SH (2010) An overview of the PubChem BioAssay resource. Nucleic Acids Res 38:D255–D266
Li Q, Cheng T, Wang Y, Bryant SH (2010) PubChem as a public resource for drug discovery. Drug Discov Today 15:1052–1057
Azzaoui K, Hamon J, Faller B, Whitebread S, Jacoby E, Bender A, Jenkins JL, Urban L (2007) Modeling promiscuity based on in vitro safety pharmacology profiling data. ChemMedChem 2:874–880
Mestres J, Gregori-Puigjane E, Valverde S, Sole RV (2008) Data completeness—the Achilles heel of drug-target networks. Nat Biotechnol 26:983–984
Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43:993–1002
Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47:550–557
Kellenberger E, Schalon C, Rognan D (2008) How to measure the similarity between protein-ligand binding sites? Curr Comput Aided Drug Des 4:209–220
Yeturu K, Chandra N (2008) PocketMatch: a new algorithm to compare binding sites in protein structures. BMC Bioinformatics 9:543
Jambon M, Imberty A, Deleage G, Geourjon C (2003) A new bioinformatic approach to detect common 3D sites in protein structures. Proteins 52:137–145
Shulman-Peleg A, Nussinov R, Wolfson HJ (2004) Recognition of functional sites in protein structures. J Mol Biol 339:607–633
Xie L, Bourne PE (2008) Detecting evolutionary relationships across existing fold space, using sequence order-independent profile-profile alignments. Proc Natl Acad Sci U S A 105:5441–5446
Brylinski M (2014) eMatchSite: sequence order-independent structure alignments of ligand binding pockets in protein models. PLoS Comput Biol 10:e1003829
Brylinski M, Feinstein WP (2013) eFindSite: improved prediction of ligand binding sites in protein models using meta-threading, machine learning and auxiliary ligands. J Comput Aided Mol Des 27:551–567
Feinstein WP, Brylinski M (2014) eFindSite: enhanced fingerprint-based virtual screening against predicted ligand binding sites in protein models. Mol Inform 33:135–150
Hartshorn MJ (2002) AstexViewer: a visualisation aid for structure-based drug design. J Comput Aided Mol Des 16:871–881
Polovnikova ES, McLeish MJ, Sergienko EA, Burgner JT, Anderson NL, Bera AK, Jordan F, Kenyon GL, Hasson MS (2003) Structural and kinetic analysis of catalysis by a thiamin diphosphate-dependent enzyme, benzoylformate decarboxylase. Biochemistry 42:1820–1830
Arjunan P, Chandrasekhar K, Sax M, Brunskill A, Nemeria N, Jordan F, Furey W (2004) Structural determinants of enzyme binding affinity: the E1 component of pyruvate dehydrogenase from Escherichia coli in complex with the inhibitor thiamin thiazolone diphosphate. Biochemistry 43:2405–2411
Kluger R, Gish G, Kauffman G (1984) Interaction of thiamin diphosphate and thiamin thiazolone diphosphate with wheat germ pyruvate decarboxylase. J Biol Chem 259:8960–8965
O’Brien TA, Gennis RB (1980) Studies of the thiamin pyrophosphate binding site of Escherichia coli pyruvate oxidase. Evidence for an essential tryptophan residue. J Biol Chem 255:3302–3307
Nemeria N, Yan Y, Zhang Z, Brown AM, Arjunan P, Furey W, Guest JR, Jordan F (2001) Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by thiamin 2-thiazolone and thiamin 2-thiothiazolone diphosphates. Evidence for reversible tight-binding inhibition. J Biol Chem 276:45969–45978
Berthold CL, Moussatche P, Richards NG, Lindqvist Y (2005) Structural basis for activation of the thiamin diphosphate-dependent enzyme oxalyl-CoA decarboxylase by adenosine diphosphate. J Biol Chem 280:41645–41654
Machius M, Wynn RM, Chuang JL, Li J, Kluger R, Yu D, Tomchick DR, Brautigam CA, Chuang DT (2006) A versatile conformational switch regulates reactivity in human branched-chain alpha-ketoacid dehydrogenase. Structure 14:287–298
Zhang Y, Skolnick J (2004) Scoring function for automated assessment of protein structure template quality. Proteins 57:702–710
Kuhn HW (1955) The Hungarian method for the assignment problem. Naval Research Logistics Quarterly 2:83–97
Munkres J (1957) Algorithms for the assignment and transportation problems. J Soc Ind Appl Math 5:32–38
Sipser M (2004) Time Complexity. In: Sipser M (ed) Introduction to the theory of computation. Thompson Learning, Inc., Cambridge, MA
Brylinski M, Skolnick J (2010) Cross-reactivity virtual profiling of the human kinome by X-react(KIN): a chemical systems biology approach. Mol Pharm 7:2324–2333
Irwin JJ, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
Kendall M (1938) A new measure of rank correlation. Biometrika 30:81–89
Feinstein W, Moreno J, Jarrell M, Brylinski M (2015) Accelerating the pace of protein functional annotation with Intel Xeon phi coprocessors. IEEE Trans Nanobioscience 14:429–439
Feinstein WP, Brylinski M (2015) Accelerated structural bioinformatics for drug discovery. In: Jeffers J, Reinders J (eds) High performance parallelism pearls volume two. Morgan Kaufmann, Waltham, pp 55–72
Acknowledgments
The research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R35GM119524. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Brylinski, M. (2017). Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning. In: Kihara, D. (eds) Protein Function Prediction. Methods in Molecular Biology, vol 1611. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7015-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7015-5_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7013-1
Online ISBN: 978-1-4939-7015-5
eBook Packages: Springer Protocols